Massachusetts Financial Services Co. MA Reduces Holdings in Humana Inc. (NYSE:HUM)

Massachusetts Financial Services Co. MA decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 1.1% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 275,837 shares of the insurance provider’s stock after selling 3,092 shares during the period. Massachusetts Financial Services Co. MA owned approximately 0.23% of Humana worth $103,066,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Intech Investment Management LLC grew its stake in shares of Humana by 46.2% during the fourth quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock worth $19,359,000 after acquiring an additional 13,356 shares during the last quarter. AdvisorShares Investments LLC purchased a new stake in shares of Humana during the fourth quarter worth about $421,000. Sei Investments Co. grew its stake in shares of Humana by 0.4% during the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after acquiring an additional 264 shares during the last quarter. Cetera Advisors LLC grew its stake in shares of Humana by 472.1% during the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after acquiring an additional 8,333 shares during the last quarter. Finally, Cetera Investment Advisers grew its stake in shares of Humana by 249.0% during the first quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after acquiring an additional 14,944 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Up 1.1 %

Shares of HUM stock opened at $315.29 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. The company has a market cap of $37.99 billion, a price-to-earnings ratio of 19.63, a PEG ratio of 2.56 and a beta of 0.50. The stock has a 50 day simple moving average of $360.50 and a 200-day simple moving average of $346.16. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the previous year, the business earned $8.94 earnings per share. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities research analysts expect that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.12%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is 22.04%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Truist Financial lifted their target price on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a report on Monday, July 15th. Morgan Stanley assumed coverage on Humana in a report on Monday, June 24th. They set an “equal weight” rating and a $374.00 target price for the company. Piper Sandler assumed coverage on Humana in a report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 target price for the company. Royal Bank of Canada lifted their target price on Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, September 5th. Finally, Baird R W raised Humana to a “hold” rating in a report on Thursday, May 30th. Thirteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus target price of $398.70.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.